Skip to main content
$55.00 +0.33 (+0.60%)
Market Cap
$174.55M
Shares
3.19M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$54.67 Open$53.91 Day$53.23–55.73 52W$23.47–68.99 Avg vol 30d93K Short int157K · 4.9% float · 1.6d Short vol65% DataJan 2020–Jul 2026 Filing10-Q · Apr 30

Up next

FQ1-27 quarter ends
~Sep 30, 2026 Est
filed Apr 30, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Bearish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.61
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +18%
above
Price vs 50-day avg −11%
below
RSI (14) 41
neutral
MACD trend Negative
52-week position 69%
mid-range
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Strong
1-month return −16%
trailing
6-month return +39%
trailing
YTD return +42%
this year
Relative strength +32%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $62 › 200d $46 — 50d above 200d
Institutional flow Distributing
6 of 57 funds reported for Jun 30 · net -137 sh shares · +1 new
Insider flow Distributing
Net -$626.2K over 90 days · 100% sells
Short interest Rising
4.92% of float · ▲ +5.7% MoM · 1.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
57 holders — near 3-yr high, broad support
Squeeze score 58
elevated · 0–100
Fundamentals
Strong
Revenue growth +24%
Y/Y
Gross margin 29%
expanding
EPS growth +345%
Y/Y
Free cash flow $-3.3M
Valuation P/E 15.2
below peers
Balance sheet $15.4M
net debt
Quant / Vol
risk profile
Very High
Volatility 65%
annualized · 1-yr
Max drawdown −55%
past year
ATR 6.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+18% Bullish
Price vs 50-day avg
−11% Bearish
RSI (14)
41 Neutral
MACD trend
Negative Bearish
52-week position
69% Neutral
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $62 › 200d $46 — 50d above 200d
Institutional flow Distributing
6 of 57 funds reported for Jun 30 · net -137 sh shares · +1 new
Insider flow Distributing
Net -$626.2K over 90 days · 100% sells
Short interest Rising
4.92% of float · ▲ +5.7% MoM · 1.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
57 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $23 Now $55 · 69% 52-wk high $69
vs 200-day avg +18% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PDEX
Pro Dex Inc
this stock
$174.55M +42.1% +23.7% 15.2 4.9%
ISRG
Intuitive Surgical Inc
$117.30B -41.4% +20.5% 38.1 1.9%
MDLN
Medline Inc.
$49.43B -10.4% +11.5% 2.2%
BDX
Becton Dickinson & Co
$42.15B +1.6% +8.2% 58.1 3.8%
ALC
Alcon Inc
$32.78B -14.7% +10.5% 2.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
57
% held
23.0%
Reported
6 of 57
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
89
View
Short & Settlement
Short Interest Rising
Shares short
157.1K
Days to cover
1.6d
Change
+8.4K sh
View
Short Volume
Short vol %
65%
As of
Jul 24, 2026
Short Total
View
Fails to Deliver
FTD shares
2
Value
$130
As of
Jun 4, 2026
View
Off-Exchange
Off-exchange %
40.3%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$626.2K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$66.6M
Net income (FY)
$9.0M
EPS diluted
$2.67
View
Buybacks
Authorized
shares 1.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 17, 2026
This year
7
View
Proposed Sales
Value
$628.4K
Shares
10.0K
Filed
May 21, 2026
View

Performance

5D 20D 120D MTD YTD
PDEX -7.5% -15.5% +38.7% -6.6% +42.1%
SPY -1.7% +0.7% +6.4% -1.2% +8.3%
vs SPY -5.8% -16.2% +32.4% -5.5% +33.8%

Capital returns

Buyback program · as of Sep 30, 2022
Authorized
shares 1.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 788920 CUSIP 74265M205 13F (30d) 6 filings 6 filers Visit website Investor relations